Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting

DRUG : 39.88 (-0.75%)
DRUG.CN : 57.4400 (+6.10%)
Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

The reason for the stock's rapid ascent is a mystery.

DRUG : 39.88 (-0.75%)
NVDA : 137.01 (-2.09%)
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

DRUG : 39.88 (-0.75%)
DRUG.CN : 57.4400 (+6.10%)
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

DRUG : 39.88 (-0.75%)
DRUG.CN : 57.4400 (+6.10%)
MarketBeat Week in Review – 10/14 - 10/18

Stocks struggled for direction, but the trend before tech earnings is still bullish. Nevertheless, investors should expect volatility ahead of the election.

WHR : 115.17 (-0.74%)
DRUG : 39.88 (-0.75%)
GOOGL : 192.76 (-1.45%)
NVDA : 137.01 (-2.09%)
CRWD : 354.99 (-2.76%)
CVX : 144.00 (+0.01%)
BAC : 44.34 (-0.47%)
OXY : 48.56 (+0.75%)
TSLA : 431.66 (-4.95%)
ABT : 114.99 (-0.24%)
XOM : 106.48 (-0.01%)
HOOD : 39.02 (-3.37%)
Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

DRUG : 39.88 (-0.75%)
DRUG.CN : 57.4400 (+6.10%)
Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

DRUG : 39.88 (-0.75%)
DRUG.CN : 57.4400 (+6.10%)
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNAâ„¢ Technology

DRUG : 39.88 (-0.75%)
AIFF : 2.62 (-2.96%)
DRUG.CN : 57.4400 (+6.10%)
Bright Minds Biosciences Stock Surges Almost 1,500%

Bright Minds Biosciences (NASDAQ: DRUG) soared 1,445% in a single day, trading over 100 million shares without any news.

DRUG : 39.88 (-0.75%)
Bright Minds is Unaware of Any Material Changes

Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - At the request of CIRO, Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") wishes to confirm that...

DRUG : 39.88 (-0.75%)
DRUG.CN : 57.4400 (+6.10%)

Barchart Exclusives

4 Highest-Rated Dividend Aristocrats To Buy Now
These three highly-rated companies offer a combination of growth and at least 25 years of increasing dividends. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar